Laptop

In the News

June 2022

Britecyte’s Research Project “A Mesenchymal Stem Cell Containing Matrix for Nonalcoholic Steatohepatitis (NASH)”  was awarded a $270,000 Commercialization Program Grant from the Maryland Stem Cell Research Fund (MSCRF)